Upgrade to SI Premium - Free Trial

SMNR (SMNR)

0.61 +0.11 (22.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/18/25 *Est.)

Latest Headlines

Form 10-Q Semnur Pharmaceuticals, For: Jun 30 August 10, 2026 4:55 PM - SEC Filing Form 424B3 Semnur Pharmaceuticals, July 7, 2026 10:49 AM - SEC Filing Form 8-K Semnur Pharmaceuticals, For: Jul 03 July 7, 2026 10:41 AM - SEC Filing Semnur signs $100M binding term sheet with Kazakhstan investor July 7, 2026 6:00 AM - StreetInsider Semnur Pharmaceuticals, Inc. (“Semnur”), a Majority-Owned Subsidiary of Scilex Holding Company (Nasdaq: SCLX, “Scilex”), Announces Signing of Binding Term Sheet for Proposed $100 Million Strat July 7, 2026 6:00 AM - Globe NewsWire Form 424B3 Semnur Pharmaceuticals, July 1, 2026 6:07 AM - SEC Filing Form SCHEDULE 13D/A Semnur Pharmaceuticals, Filed by: Scilex Holding Co June 26, 2026 4:24 PM - SEC Filing Form 4 Semnur Pharmaceuticals, For: Jun 15 Filed by: Scilex Holding Co June 26, 2026 4:20 PM - SEC Filing Form 8-K Semnur Pharmaceuticals, For: Jun 25 June 25, 2026 5:04 PM - SEC Filing Full Article List